Systems biology is based on the computer modelling of biological systems, ranging from single cells up to complete organisms. As an emerging interdisciplinary science, it combines methods from molecular biology, engineering sciences, mathematics, information technology, and systems sciences. As well as obvious medical applications, systems biology has the potential to have a significant impact on agriculture and biotechnology.
'Systems biology is a fantastically powerful approach and very versatile - as demonstrated by the range of projects funded through ERASYSBIO+,' said Professor Douglas Kell, Chief Executive of the UK's Biotechnology and Biological Sciences Research Council (BBSRC) and member of the ERASYSBIO+ ('The consolidation of systems biology research - stimulating the widespread adoption of systems approaches in biomedicine, biotechnology, and agri-food') consortium.
A total of 85 research groups from 14 different countries are involved in the projects, which include C5SYS ('Circadian and cell cycle clock systems in cancer'), SHIPREC ('Living with uninvited guests comparing plant and animal responses to endocytic invasions'), FRIM ('Fruit integrative modelling'), and GRAPPLE ('Iterative modelling of gene regulatory interactions underlying stress, disease and ageing in C. elegans').
'These projects not only bring together disciplines, but also countries, and this is the sort of collaborative working that is becoming increasingly important. If we are to make the best use of our bioscience knowledge, expertise and facilities in the UK then we absolutely must share them with colleagues outside the UK and in other fields such as mathematics, computing, chemistry and physics,' added Professor Kell.
The original ERASYSBIO ('Towards a European Research Area for systems biology - a transnational funding initiative to support the convergence of life sciences with information technology and systems sciences') ERA-NET ran from 2006 to 2009. It represented the first intense collaboration between the systems biology community and major funding agencies in several European countries. The initiative was an opportunity for agencies to coordinate their national research programmes in systems biology and to agree on a common agenda with joint activities.
Its successor, ERASYSBIO+, is an ERA-NET Plus action which provides additional EU financial support to facilitate joint calls for proposals between national and/or regional programmes (compared to an ERA-NET action, which provides the framework for bringing together stakeholders).
The focus of the ERASYSBIO+ consortium for the next five years will be to implement transnational funding activities for systems biology, such as the 16 recently-launched projects. A total of EUR 18.5 million in support of the research was provided by the partner countries themselves, while the EU contributed a further EUR 5.5 million.
ERASYSBIO+ is made up of 16 ministries and funding agencies from 13 countries. Partners of national programmes include representatives from Austria, Belgium, Finland, France, Germany, Israel, the Netherlands, Norway, Slovenia, Spain and the UK. The objective of the ERA-NET scheme is to build the European Research Area by developing and strengthening the coordination of national and regional research programmes.
For more information, please visit:ERASYSBIO:
Document Reference: Based on information from BBSRC and ERASYSBIO+
The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences
Transforming plant cells from generalists to specialists
07.12.2016 | Duke University
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine